Agnovos Healthcare LLC, a company using regenerative medicine to treat localized effects of bone disease, has received the FDA’s nod for an IDE clinical trial to assess its AGN1 local osteo-enhancement procedure (LOEP) small-volume (SV) kit in patients with vertebral compression fractures (VCFs). The investigational device is intended to treat stable but painful VCFs via a minimally invasive procedure. The kit, which comes in the form of two single-use trays, contains a calcium-based, resorbable, triphasic implant material that is designed to align the pace of resorption with bone formation, providing treated vertebrae with immediate and durable protection.
Keeping you up to date on recent developments in orthopedics, including: X-rays confirm promise of new luminescent markers; Pillar of support: Breakthrough discovery could speed up bone implant recovery; New biosealant can stabilize cartilage, promote healing after injury.
Keeping you up to date on recent developments in orthopedics, including: New study expands evaluation of gene therapy for spinal muscular atrophy; High risk of AKI in patients undergoing treatment for infected total knee replacement; Tadpole nerve regeneration capacity provides clue to treating spinal cord injury.
The FDA has granted 510(k) clearance to Orthofix Medical Inc.’s Construx Mini Ti spacer system for anterior cervical discectomy and fusion (ACDF) procedures. Company documents claim the implant has an optimized porosity and pore size, which creates a 3D porous surface with the potential for bone ingrowth.
TORONTO – Robotics researchers at Ontario’s University of Waterloo are stealing a page from makers of autonomous or self-driving vehicles, developing wearable, motor-controlled technology to restore physical mobility in people with disabilities without the need to think about or guide the system. The project, called Exonet, is being led by Brokoslaw Laschowski, who contrasts this approach with engineers ramping up the ability of users to control the exoskeleton.
Keeping you up to date on recent developments in orthopedics, including: Scientists use nanotechnology to detect bone-healing stem cells; Premia reports FDA breakthrough device designation for Its Tops system; 'Break a leg' not so lucky when it leads to limb deformities.
PARIS – Implanet SA won approval from its founding shareholders to acquire a majority stake in spinal implant manufacturer Orthopaedic & Spine Development SAS (OSD). Implanet’s bid is aimed at acquiring majority control, and potentially the entire share capital, of Avignon, France-based OSD, valued at $5 million. OSD’s founding shareholders, representing 71.5% of the capital, have already committed to respond favorably to the bid, thus confirming the principles behind this merger.
HONG KONG – Israel and U.S.-based Rsip Vision Ltd. unveiled an advanced joint segmentation tool to assist with the planning of revision arthroplasty and other orthopedic procedures for patients with pre-existing metal implants. The detailed, noninvasive artificial intelligence (AI)-based software module enables quick and accurate segmentation of different joints from CT scans of hips, knees, shoulder and spines.
Keeping you up to date on recent developments in orthopedics, including: TKR a cost-effective treatment for patients with knee osteoarthritis; Nonsurgical treatment quickly reduces arthritis knee pain and improves function; Inflammation and pressure-sensing leads to 'feed-forward' loop in osteoarthritis.
Thirteen months after establishing a strategic alliance to distribute 7D Surgical Inc.’s machine-vision, image-guided surgery platform, Seaspine Holdings Corp. (NASDAQ:SPNE) signed an agreement to acquire the Toronto-based company. 7D Surgical shareholders will receive $27.5 million in cash plus $82.5 million in Seaspine stock and will hold approximately 13% of Seaspine’s shares at completion. The deal is expected to close in the second quarter of 2021.
RSS
